Restricted accessOtherFirst published online 2008-12
Association Between Protein-Bound Sialic Acid and High-Sensitivity C-Reactive Protein in Essential Hypertension: A Possible Indication of Underlying Cardiovascular Risk
The aim of this study was to examine the possible alteration in the levels of C-reactive protein, protein-bound sialic acid, and other lipid risk factors in newly diagnosed essential hypertensive subjects. In all, 56 hypertensive and 33 normotensive male subjects were enrolled in the study. Lipid profile, C-reactive protein, apolipoprotein-B, and protein-bound sialic acid were estimated in both the groups. Total cholesterol, triglyceride, low-density lipoprotein—cholesterol, C-reactive protein, apolipoprotein-B, and protein-bound sialic acid were significantly increased in patients with essential hypertension. Correlation analysis revealed a significant association between the protein-bound sialic acid with mean arterial pressure, C-reactive protein, and low-density lipoprotein—cholesterol. The findings of the present study suggest that in essential hypertension there is an association between protein-bound sialic acid and C-reactive protein, which reflects the clustering of cardiovascular risk factors in these patients.
Chockalingam A., Ganeshan N., Venkatesan S., et al. Patterns and predictors of prehypertension among healthy urban adults in India. Angiology. 2005;56:557-563.
2.
Gupta R.Trends in hypertension epidemiology in India. J Hum Hypertens . 2004;18:73-78.
3.
Morrow D., Ridker P.Inflammation in cardiovascular disease. In: Topol E, ed. Textbook of cardiovascular medicine updates. Cedar Knolls, NJ: Lippincott-Williams & Wilkins;1999:63-71.
4.
Libby P., Ridker PM, Maseri A.Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
5.
Gopaul KP, Crook MASialic acid: a novel marker of cardiovascular disease? Clin Biochem. 2006;39:667-681.
6.
Mazer SP, Rabbani LEEvidence for C-reactive protein's (CRP) role in vascular disease: atherothrombosis, immunoregulation and CRP. J Thromb Thrombolysis . 2004; 17:95-105.
7.
Lindberg G., Eklund G., Gullberg B., Rastam L.Serum sialic acid concentration and cardiovascular mortality. Br Med J. 1991;302:143-146.
8.
Lindberg G., Rastam L., Gullberg B., Eklund GASerum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol.1992;21:253-257.
9.
Mathew S., Menon PV, Kurup PAEffect of administration of carnitine on the severity of myocardial infarction induced by isoproterenol in rats. Aust J Exp Biol Med Sci . 1986;64:79-87.
10.
Hackam DG, Anand SSEmerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290:932-940.
11.
Danesh J., Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med . 2004;350:1387-1397.
12.
Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100:96-102.
13.
Chae CU, Lee RT, Rifai N., Ridker PMBlood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399-403.
14.
Sesso HD, Buring JE, Rifai N., Blake GJ, Gaziano JM, Ridker PMC-reactive protein and the risk of developing hypertension. JAMA. 2003;290:2945-2951.
15.
Lowe GDBlood viscosity and cardiovascular risk. Thromb Haemost . 1992;67:494-498.
16.
Hokanson JE , Austin MAPlasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
17.
Koba S., Hirano T., Yoshino G., et al. Remarkably high prevalence of small low-density lipoprotein in Japanese men with coronary artery disease irrespective of the presence of diabetes. Atherosclerosis. 2002;160:249-256.
18.
Chobanian AV , Bakris GR, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003 ;289:2560-2572.
19.
Aminoff D.Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961;81:384-392.
20.
de Beer FC, Hind CRK, Fox KM, Allan RM, Maseri A., Pepys MBMeasurement of C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J. 1982;47:239-243.
21.
Anzai T., Yoshikawa T., Shiraki H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 1997;96:778-784.
22.
Sung KC, Suh JY, Kim BS, et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens. 2003;16:429-433.
23.
Bautista LE , Lopez-Jaramillo P., Vera LM, Casas JP, Otero AP, Guaracao AIIs C-reactive protein an independent risk factor for essential hypertension? J Hypertens. 2001;19:857-861.
24.
Sinisalo J. , Paronen J., Mattila KJ, et al. Relation of inflammation to vascular function in patients with coronary heart disease . Atherosclerosis . 2000;149:403-411.
25.
Allain P., Oliver E., Le-Bouil A., Benoit C., Geslin P., Tadei A.Increase of sialic acid concentration in the plasma of patients with coronary disease. Presse Med. 1996; 25:96-98.
26.
Crook M., Haq M., Haq S., Tutt P.Plasma sialic acid and acute phase proteins in patients with myocardial infarction . Angiology. 1994;45:709-715.
27.
Thirurasundari CJ, Jayalakshmi R., Niranjali DSLiver architecture maintenance by tincture of crataegus against isoproterenol-induced myocardially infracted rats. J Med Food. 2005;8:400-404.
28.
Gracheva EV , Golovanova NK, Kononova OI, Kozlov SG, Prokazova NV, Liakishev AABlood sialic acids in atherosclerosis. Biokhimiia. 1995 ;60:718-722.
29.
Alexander RWHypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995;25:155-161.
30.
Sesso HD, Stampfer MJ, Rosner B., Hennekens CH, Gaziano JMSystolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension . 2000; 36:801-807.
31.
Tsioufis C., Dimitriadis K., Taxiarchou E., et al. Diverse associations of microalbuminuria with C-reactive protein, interleukin-8 and soluble CD 40 ligand in male essential hypertensive subjects . Am J Hypertens. 2006;19:462-466.
32.
Chavan MM, Kawle PD, Mehta NGIncreased sialylation and defucosylation of plasma proteins are early events in the acute phase response. Glycobiology. 2005;15:838-848.
33.
Salonen JT, Lakka JA, Lakka HM, Valkonen VP, Everson SA, Kaplan GAHyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes. 1998;47:270-275.
34.
Ridker PM, Rifai N., Cook NR, Bradwin G., Buring JENon-HDL Cholesterol, apolipoproteins A-1 and B100, standard lipid measures, lipid ratios and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326-333.
35.
Lemieux I., Lamarche B., Couillard C., et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/ HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec cardiovascular study. Arch Intern Med. 2001;61:2685-2692.
36.
Yoshida A., Kouwaki M., Matsutani Y., Fukuchi Y., Naito M.Usefulness of serum total cholesterol/triglyceride ratio for predicting the presence of small dense LDL. J Atheroscler Thromb. 2004;11:215-219.
